292 related articles for article (PubMed ID: 15724090)
1. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis.
Bigliardi-Qi M; Lipp B; Sumanovski LT; Buechner SA; Bigliardi PL
Dermatology; 2005; 210(2):91-9. PubMed ID: 15724090
[TBL] [Abstract][Full Text] [Related]
2. Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin.
Bigliardi-Qi M; Sumanovski LT; Büchner S; Rufli T; Bigliardi PL
Dermatology; 2004; 209(3):183-9. PubMed ID: 15459530
[TBL] [Abstract][Full Text] [Related]
3. Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
Bigliardi-Qi M; Gaveriaux-Ruff C; Pfaltz K; Bady P; Baumann T; Rufli T; Kieffer BL; Bigliardi PL
J Invest Dermatol; 2007 Jun; 127(6):1479-88. PubMed ID: 17185983
[TBL] [Abstract][Full Text] [Related]
4. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
Dou YC; Hagströmer L; Emtestam L; Johansson O
Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis.
Tengara S; Tominaga M; Kamo A; Taneda K; Negi O; Ogawa H; Takamori K
J Dermatol Sci; 2010 Apr; 58(1):64-71. PubMed ID: 20219326
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
7. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch.
Taneda K; Tominaga M; Negi O; Tengara S; Kamo A; Ogawa H; Takamori K
Br J Dermatol; 2011 Aug; 165(2):277-84. PubMed ID: 21457210
[TBL] [Abstract][Full Text] [Related]
9. Expression of mu-opiate receptor in human epidermis and keratinocytes.
Bigliardi PL; Bigliardi-Qi M; Buechner S; Rufli T
J Invest Dermatol; 1998 Aug; 111(2):297-301. PubMed ID: 9699733
[TBL] [Abstract][Full Text] [Related]
10. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis.
Tominaga M; Ogawa H; Takamori K
J Invest Dermatol; 2007 Sep; 127(9):2228-35. PubMed ID: 17611580
[TBL] [Abstract][Full Text] [Related]
11. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.
Li Z; Proud D; Zhang C; Wiehler S; McDougall JJ
Arthritis Rheum; 2005 Oct; 52(10):3210-9. PubMed ID: 16200625
[TBL] [Abstract][Full Text] [Related]
12. Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications.
Tominaga M; Takamori K
J Dermatol; 2014 Mar; 41(3):205-12. PubMed ID: 24628070
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions.
Ohmen JD; Hanifin JM; Nickoloff BJ; Rea TH; Wyzykowski R; Kim J; Jullien D; McHugh T; Nassif AS; Chan SC
J Immunol; 1995 Feb; 154(4):1956-63. PubMed ID: 7836775
[TBL] [Abstract][Full Text] [Related]
14. beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis.
Bigliardi-Qi M; Bigliardi PL; Eberle AN; Büchner S; Rufli T
J Invest Dermatol; 2000 Mar; 114(3):527-32. PubMed ID: 10692113
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
16. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
[TBL] [Abstract][Full Text] [Related]
19. Association of stress with symptoms of atopic dermatitis.
Oh SH; Bae BG; Park CO; Noh JY; Park IH; Wu WH; Lee KH
Acta Derm Venereol; 2010 Nov; 90(6):582-8. PubMed ID: 21057740
[TBL] [Abstract][Full Text] [Related]
20. [Role of the skin expression of neuropeptides, neurotrophins and their receptors in the pathogenesis of dermatoses].
Smolyannikova VA; Kubanova AA; Karamova AE; Nefedova MA; Chikin VV
Arkh Patol; 2015; 77(4):33-39. PubMed ID: 26485778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
